SCHEMBL20037633

SCHEMBL20037633

CC(C)(C)OC(=O)N1CN(c2ccc(N)nc2)C(=O)C(C)(C)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.42
▸ ALOX5AP P20292 2/20 0.38
▸ FEN1 P39748 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ USP30 Q70CQ3 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ BACE1 P56817 2/20 0.36
▸ CTSD P07339 1/20 0.36
▸ CTSE P14091 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ GPR119 Q8TDV5 3/20 0.35
▸ PIK3CA P42336 2/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20255183 0.90 USP30 (0.42) NR1H2ALOX5APFEN1SMN1; SMN2RAB9A
SCHEMBL18291721 0.78 ALOX5AP (0.40) NR1H2ALOX5APFEN1SMN1; SMN2MAPT
SCHEMBL18291496 0.78 USP30 (0.53) SMN1; SMN2MAPTMEN1TSHRKMT2A
SCHEMBL30484801 0.77 EGLN2 (0.46) ALOX5APFEN1SMN1; SMN2MAPTMEN1
SCHEMBL611746 0.77 EGLN2 (0.46) ALOX5APFEN1SMN1; SMN2MAPTMEN1
SCHEMBL29741868 0.76 GPR119 (0.50) NR1H2ALOX5APFEN1SMN1; SMN2MAPT
SCHEMBL29491152 0.76 MAPT (0.44) NR1H2SMN1; SMN2MAPTMEN1TSHR
SCHEMBL255485 0.76 MAPT (0.44) NR1H2SMN1; SMN2MAPTMEN1TSHR
SCHEMBL2300710 0.75 HRH3 (0.54) ALOX5APFEN1SMN1; SMN2MAPTMEN1
SCHEMBL2301444 0.75 ITGB3 (0.50) SMN1; SMN2MAPTMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback